CSI Market
Sign In | Register

Decoy Therapeutics Inc (DCOY) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DCOY Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Decoy Therapeutics Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/DCOY/balance-sheets
https://api.csimarket.com/api/v1/companies/DCOY/fundamentals
https://api.csimarket.com/api/v1/companies/DCOY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent8.17
Cash, Cash Equivalents Other0.00
Restricted Cash2.50
Cash & Short-term Investments8.00
Prepaid Expense And Other Assets Current0.22
Total Current Assets8.38
Equipment/Property/Plant Net0.39
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.03
Total Assets8.79
Liabilities
Accounts Payable, Current AC0.78
Other Liabilities, Current0.78
Deferred Revenue DE2.69
Total Current Liabilities4.25
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Related Party Deposit Liabilities0.14
Total Liabilities4.25
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock106.57
Retained Earnings / Accumulated Deficit-102.03
Other Equity0.00
Common Stockholder's Equity4.55
Total Stockholder's Equity4.55
Liabilities & Stockholder's Equity8.79
4 historic quarters locked

Sign in to unlock the full Decoy Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Decoy Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 12, 2026
  • Source: dcoy-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-458490

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI